news
XenaCare Holdings Announces Updates to Cobroxin Distribution and National
Advertising Campaign
XenaCare Holdings Has Announced that Cobroxin Has Begun
Selling in Mass Food and Drug Retail Chains in the Northeast, Southeast, Middle
Atlantic and Midwest Regions; Additionally, the Company Has Committed to a $7
Million National Advertising Campaign and Direct Response Marketing Campaign
DELRAY BEACH, Fla., Feb 11, 2010 (BUSINESS WIRE) -- XenaCare Holdings, Inc.
(OTCBB:XCHO), a company specializing in the marketing and retail distribution of
consumer healthcare products, announced today that it has begun distributing and
selling Cobroxin through mass food and drug retail chains in the Northeast,
Southeast, Middle Atlantic and Midwest regions. The Company has also announced
that sales of Cobroxin have exceeded projections for the first 45 days of 2010.
"Sales of Cobroxin have already exceeded our projections for the beginning of
this year," explained Frank Rizzo, President and CEO of XenaCare Holdings.
"Reorder rates from our customers have been very strong at all levels of our
distribution grid and have required us to reorder inventory four times from
Nutra Pharma since placing our initial order for the product," he added.
To support sales of Cobroxin, XenaCare has committed to a $4 million print
advertising campaign for the first 12-months. This campaign includes
advertisements in Health, Prevention, Self, Soap Opera Digest, Working Mother,
Woman's Day, Shape, Martha Stewart, Redbook, Ladies Home Journal, Allure, Wired,
Web M.D. and Arthritis Today magazines.
In addition to its national print campaign, the Company has contracted with the
Home Shopping Group to organize direct response television commercials set to
begin airing in March 2010. Additionally, the Company has committed to a $3
million television broadcast campaign.
